{"paper_id":"c1df9dc6-e18b-4f02-83e6-417b9411ce6e","body_text":"424ߨ\nPharmacotherapeutics\n੗\nࢿ\nࠁ\nੌ\nૐ਷ ਘ҃\n੸ੋ ஖\nয\n੄ ਗ஗੉\n৉\n֙\nాૐઑ\nח۽ٜ\n׮\nॳ੉Ҋ ੓ਵ\n਑\n੘ਊਸ ઴\n੗Ҿ\nఖ੸\nਊ୓ ઑ੺ઁ\t413.\n\r\u0001$09\u000e\u0013 রઁઁ\r\u0001ആҙ\n\u0001\u000f׮\nૐ੄ बೠ\nח׮\nജ੗੄\n੸ ੽Ӕ੉\n\u000f׮ػ\nߨ\nMedical Therapy of Endometriosis\nੋҗ೟Үप ]Ae-Ra Kang, MD hJun Young Hur, MD\nDepartment of Obstetrics and Gynecology, Korea University College of Medicine\n* Corresponding author : Jun Young Hur\nE - mail : junyhur@yahoo.co.kr\nJ Korean Med Assoc 2010; 53(5): 424 - 429\nE\nndometriosis is a common, benign, and chronic gynecologic disorder. It is an Estrogen\ndependent disease that can cause pelvic pain, dysmenorrhea, and infertility. GnRH\nagonists, Danazol, progestogens, and oral contraceptives have been conventionally used for the\nmedical treatment of endometriosis. Increasing knowledge about endometriosis has introduced\nmore new targeted agents for endometriosis. Further study might be required to evaluate effecti-\nveness and safety of new agents.\nKeywords:Endometriosis; Medical treatment\n೨बਊয \u001b \u0001ߨ\nAbstract\n\n\nഈഥ૑ 425\nߨMedical Therapy of Endometriosis\nٜ\n҃ҳೖ੐ড\n݄\n੄\nನ\nࣘ\nOPS\u000e\nਸ ೣਬೠ ҃ҳೖ\n۽\n਍EFTPHFTUSFM\u0001ೣਬઁઁ ৉द ബҗ੸\nࢎ\n\u000f׮\nبߣ\n҃ҳೖ੐\nܳب\nبۄ\n૑ ঋ਷ ҵ\n҃ҳೖ੐\n੄ х\n҃ҳೖ੐ઁ\n੄\nࣻ\n੸ ҃ҳೖ੐\n࠺\nࢲ\nߨ\n\u000f׮\nҵҗ ઱ӝ੸ ҃ҳ\nܳ\nਃ\n੉ ਬ੄\n੸ ҃ҳೖ੐\nו\n\u000f\n\u0012\t׮\nী ബҗ\nѪ੉ р\n੿\nחࠁ\nח\nҮ੸ ਊ੉ೞҊ\nࢶ\n\u000f׮ػ\nѱझషѲ \t1SPHFTUPHFO\nѱझషѲ਷.1\"\u0001 \tNFESPYZ\u000eQSPHFTUFSPOF\u0001 BDF\u000e\n݄\nബ\nਤ୷\n1\u0001\tNBUSJY\u0001NFUBMMP\u000e\nFDUPQJD\u0001 &OEP\u000e\n\u0001\u000f׮\nPSUFTUP\u000e\n۽\n୭\nъ҃ਵ\nܳ\n೧\nࢲ\n\u000f׮\n੿\nী ӛ੿੸ੋ\nী\n੢੼੉ ੓\n੄\nח\nػ\n੉\n\u000f׮\nࢶ\nHPOBEPUSPQIJO\n੄ \u0012\u0018\u000eIZESPYZQSPHFTUFSPOF\n҃ҳೖ੐ড\tEFTPHFTUSFM\n\n\n426ߨ\nKang ARhHur JY\nҮೠ োҳী\nח\nജ੗о ҃\nೖ೧\n਄\n\u000f׮\n੄ উ\nо੢\nܖ\n1\"\u0001\t%FQPU\u0001GPSNVMBUJPO\u0001PG\u0001.F\u000e\nా \u0012\u0016\u0011\u0001 NHਸ \u0014ѐਘী\n࠼\nب࠼\n۽\nࠗ\nѐ\nড\nࣻ\n\u000f\n\u0014\t׮\nੑറ\n੗Ҿղ੢\nѲ\nର੸ੋ ബҗо\n֙\n୹ೞৈ\nী\nా\r\nա അ੤\n\u000f׮\nয়\n੓ਵ\nా੉ա х৏੄ ਤ೷੉\n઺\n੗Ҿ\nҮ\n੉ \u0012\u0011\u0006\nী\n\u0001\u000f׮\n੘ਊઁ \t(O3)\u0001\"HPOJTU\nࣻ\nػ\nхӝо ӡয\n୷ਸ ೞೱઑ੺\tEPXO\u0001 SFHVMBUJPO\nೞҊ ੷\nೞৈ ੼૓੸ਵ\nೠ ੗\n૓1MBTNJOPHFO\u0001BDUJ\u000e\nࠁܳ \nറ\nਊ\nܫߊ\nࢎ\u0001\r\u0006\u0012\u000f\u0014\u0012ࢲ \nࢠ\nਊೞ૑ ঋ\n੘ਊઁ\n\u000f׮\nഘ\n੘ਊ੉ ੓ਵ\nҊ\n਷ ઺\nܰ\n\rؘח\n࠙ހܰ \n੗\n੄ ੤\nހܰ\nࢠ\n੉\n੗ӓഐ\n׮ࠁ\n৓\n\n\nഈഥ૑ 427\nߨMedical Therapy of Endometriosis\nߊ\nѐ\n੗ӓഐ\nࣗ\n৮ೞӝ ਤ೧\n੉\n਷ ઴\nTUSPHFO\n׮݃\nড \u0012\u0011 _\u0013\u0011QH\u0010NM੄ ীझ౟\nծ\n੉\n੘ਊ੉ ੓ਵա\r\u0001 ড \u0014\u0011 _\u0015\u0016QH\u0010NM੄\n੗ӓೞ૑ ঋਵ\nदெ\nݶ\nח\n߽ۿ \n৮\nোҳী\n\u0001\u000f׮\nաઔ \t%BOB[PM\nട୓ഋ\nਸ রઁ\n\u0001\u000f׮\nੌ\nҙ଴\nా੉ \u0014ѐਘ উী അ੷൤ х\nغࣘ\n঻Ҋ\n\u000f׮\n۽\nࣗݾ\n૕৏\r\n١\n۽\nաઔ ೣਬ\nҊ ੓ਵա\n\u000f׮\nFTUSJOPOF\nࢲ\n૑ ঋਵ\nѱझ\nܰ\n੄MZTPTPNBM\nѱझషѲਸ রઁ\nח\nࢎ\n٘\n੘ਊ੉ ੓Ҋ)%-\u0001 DIPMFTUFSPM\nࠗ؀\u0001\u000f׮ \nਫ਼੤੸\n\u0001\u000f׮\nٜب\nরઁઁ \t\"SPNBUBTF\u0001*OIJCJUPST\nನ\tHSBOV\u000e\nझ\n4U\"3\nਸ\nDZUP\u000e\nоBOESPTUFOFEJPO\n݄݀\nನ\tTZODJUJPUSPQIPCMBTU\n\r\u0001 Ҋജ੄\nನ\tGJCSP\u000e\n੸\nח\nѪਵ\nח\n\n\nחࢲ\n\u000f׮\nࢲ\nझ\nࣗ\nನ\nয\n਽੉\nী ઺ਃೠ ীझ౟\nਵ\nড\nܐ\n\u000f׮\n҃\nઁ\u0013ഋ਷\nOBTUSB[PMF\u0001 \t\"SJNJEFY\n৬ -FUSP[PMF\n঻\nরઁઁੋBOBTUSP[PMF\r\u0001 MFUSP\u000e\n਋ਘೠ\n\u0001\u000f׮\n਷ MFUSP[PMF\u0001 \u0013\u000f\u0016\u0001 NHਸ /PSFUIJO\u000e\nъ҃ೞ\nҊ ೮\n਷ BOBTUSP[PMF\u0001 \u0012\u0001 NHҗ HPTFSFMJOF\n࢚\nө૑੄\nബҗ੄ ӝ\nਸরઁೞҊ\nೠ\n੉\nѲ ೤\nݡغࢿ \nغ\n݄\n۾ب\nਸ\nਊೡ\nب޻\n੗ӓ\nୡӝ\n҃ҳೖ੐ઁ৬ э\n\u000f׮ػ\nਊ୓ ઑ੺ઁ\u000e\u0001413. \t4FMFDUJWF\n1SPHFTUFSPOF\u00013FDFQUPS\u0001.PEVMBUPS\nࣻۿ \nӡ೦ઁ ഑਷ ੘ਊ\nࣻۿ \nѱझప\nUSBOTDSJQUJPO\n\u0001 ઑ੺਷ DP\u000eSFHVMBUPS\r\n\rؘח\nۿ\nೞ\nਊ୓ী\nۿ\nDP\u000e\n૕\tBOUB\u000e\nDP\u000e\n૑Ҋ ੓ਵ\nఖ੸ ೐\nۿ\nݓزࢶ\n୷ਸ ૐо\n੘\nਘ\nदః૑ ঋਵ\n৬\n\u000f׮\nTPQSJTOJM \u0016\r\nݽࢲ \n֙\u0016\u0011\u0011\u0013ݴ \nࠁ\n428ߨ\nKang ARhHur JY\n\n\nഈഥ૑ 429\n\u000f׮\n࢚\nଵ\nٜ\nغ\n୶о੸ੋ োҳо ೙\n\u000f׮ػ\nٜب\nরઁઁ\r\n5VNPS\u0001 /FDSPTJT\u0001 'BDUPS\u0001 \t5/'\n \u000eJOIJCJUPS\r\u0001 ..1\u0001 \tNBUSJY\nѱ\n\u0001\u000f׮\n਷ ҙब੉\n5*.1 \u000e \u0012\u0001\t5JTTVF\u0001*OIJCJUPST\u0001PG\u0001NBUSJY\n੄FOEPQFQ\u000e\nUJEBTFੋ ..1\u0001 \tNBUSJY\u0001 NFUBMMPQSPUFJOBTF\u0001 \n੄ ੘ਊਸ র\nъ ղ\n੗Ҿ৻ ੗\n࠙۠ \n۽\n\u000f׮\nࠁ۽ \n޷ח \n\u000f׮\nӒ\nਊী\nૐ੄ ੤\n੗\nߊ\nܖ\n\u0001\u000f׮ػ\n೴\n11. Seracchioli R, Mabrouk M, Frasca C, Manuzzi L, Savelli L,\nVenturoli S. Long-term oral contraceptive pills and postopera-\ntive pain management after laparoscopic excision of ovarian\nendometrioma: a randomized controlled trial. Fertil Steril 2009.\n12. Chu MC, Zhang X, Gentzschein E, Stanczyk FZ, Lobo RA. For-\nmation of ethinyl estradiol in women during treatment with\nnorethindrone acetate. J Clin Endocrinol Metab 2007; 92:\n2205-2207.\n13. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.\nBone density in women receiving depot medroxyprogesterone\nacetate for contraception. BMJ 1991; 303: 13-16.\n14. Jee BC, Lee JY, Suh CS, Kim SH, Choi YM, Moon SY. Impact\nof GnRH agonist treatment on recurrence of ovarian endome-\ntriomas after conservative laparoscopic surgery. Fertil Steril\n2009; 91: 40-45.\n15. Soysal S, Soysal ME, Ozer S, Gul N, Gezgin T. The effects of\npost-surgical administration of goserelin plus anastrozole\ncompared to goserelin alone in patients with severe endome-\ntriosis: a prospective randomized trial. Hum Reprod 2004; 19:\n160-167.\nߨMedical Therapy of Endometriosis\nPeer Reviewers’ Commentary\n਍ ড\nী ੄\nݺ\n۽\nࢲ\n\u000f׮ػ\nಞ૘ਤਗഥ>","source_license":"CC0","license_restricted":false}